Acute lymphoblastic leukaemia second line - dasatinib - initial authority application form (PB077)

Use this form to apply for initial PBS-subsidised treatment with dasatinib in the second-line treatment of acute lymphoblastic leukaemia.

Page last updated: 1 January 2025.
QC 20771